Last reviewed · How we verify

NCT03317600

Postamputation Pain: Peripheral Mechanisms

Completed NA Last updated 16 July 2018
What this trial tests

NA trial testing Lidocaine in Neuropathic Pain in 12 participants. Completed in 28 February 2018.

Timeline
25 October 2017
Primary endpoint
28 February 2018
28 February 2018

Quick facts

Lead sponsorDanish Pain Research Center
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingdouble
Primary purposediagnostic
Enrollment12
Start date25 October 2017
Primary completion28 February 2018
Estimated completion28 February 2018
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Danish Pain Research Center — full company profile →

Who can join

Adults 18 to 85, any sex, with Neuropathic Pain or Amputation, Traumatic. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stump and phantom pain after amputation are common, but the responsible mechanisms are still not clarified. It has been suggested that phantom limb pain can be reduced by regional anaesthesia and in several recent studies, pain was reduced following intrathecal and intraforaminal blocks. In this study, the investigators want to investigate if spontaneous and evoked pain in amputees will be relieved by regional nerve blocks involving the damaged nerves.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Lidocaine

Trials testing the same drug.

Other recruiting trials for Neuropathic Pain

Currently open trials in the same condition.

Other Danish Pain Research Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03317600.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing